COPD Clinical Trial
— REWORKOfficial title:
Resistance Training in Patients With Chronic Obstructive Lung Disease (COPD): Whole Body Vibration Versus Conventional Resistance Training
Verified date | December 2011 |
Source | University Hospital, Ghent |
Contact | n/a |
Is FDA regulated | No |
Health authority | Belgium: Ethics Committee |
Study type | Interventional |
Pulmonary rehabilitation has been emerged as a recommended standard of care for patients
with chronic lung disease based on a growing body of scientific evidence. A set of
evidence-based guidelines were published in American College of Chest Physicians (ACCP) and
the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). Since
then, the published literature in pulmonary rehabilitation has increased substantially, and
other societies have published important statements about pulmonary rehabilitation (eg, the
American Thoracic Society and the European Respiratory Society).
In patients with COPD, there is a strong scientific basis for implementing conventional
resistance training (CRT) in addition to endurance training. Endurance training, such as
walking, is a key component of pulmonary rehabilitation and improves in exercise tolerance
and muscular endurance. However, this type of training may not reverse muscle weakness or
atrophy. For that reason, strength training seems to be the optimum training modality to
increase muscle mass and strength.
Recently, Whole-Body-Vibration (WBV) training has been promoted as an alternative for
resistance training on multigym equipment. In WBV training, the subject stands on a platform
that generates vertical sinusoidal vibration, during which static and dynamic exercises can
be performed.
The present study is conducted to provide an answer on the following question: will a
resistance training program, such as the whole body vibration, be even effective than a
conventional resistance training program in patients with COPD.
Status | Completed |
Enrollment | 62 |
Est. completion date | November 2011 |
Est. primary completion date | July 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 40 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Patients with COPD candidate for pulmonary rehabilitation - Men and female between 40 and 80 years of age - Written informed consent to participate Exclusion Criteria: - Severe cardiac, neurological and orthopedic co-morbidity interfering with exercise training. - Pacemaker - Hip, knee of shoulder prosthesis or recently introduced spirals, metal pens, bolts or plates - Uncontrolled diabetes, epilepsy or migraine - Osteoporotic or metastatic fractures, acute hernia, discopathy, spondylitis |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Belgium | University Hospital Ghent | Ghent |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Ghent |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | estimation of the change of 6 MWD before and after 12 weeks resistance training program (CRT versus WBV training) | estimation of the change of 6 MWD (submaximal walking test)after a 12 week conventional resistance training program or after a 12 week whole body vibration training program | before and after 12 weeks | Yes |
Secondary | changes in muscle strength (quadriceps force)after CRT or after WBV training in patients with COPD | measured by modified Microfet before and after 12 weeks of training. | before and after 12 weeks | No |
Secondary | changes in body composition after CRT or after WBV training in patients with COPD | measured by bioelectrical impedance analysis: Fat Free Mass (FFM)before and after 12 weeks of training. | before and after 12 weeks | No |
Secondary | changes in maximal exercise capacity after CRT or after WBV training in patients with COPD | measured by cyclo-ergospirometry before and after 12 weeks of training | before and after 12 weeks | No |
Secondary | changes in muscle force after CRT or after WBV training in patients with COPD | measured by handgrip force, maximal inspiratory pressure (PImax) and maximal expiratory pressure (PEmax)before and after 12 weeks of training | before and after 12 weeks | No |
Secondary | changes in Quality of life after CRT or after WBV training in patients with COPD | measured by CRDQ (Chronic Respiratory Disease Questionnaire)before and after 12 weeks of training | beforer and after 12 weeks | No |
Secondary | changes in Dyspnea scores after CRT or after WBV training in patients with COPD | measured by Chronic Respiratory Disease Questionnaire domain dyspnea (CRDQd) and by the BORG scale before and after 12 weeks of training. | before and after 12 weeks | No |
Secondary | changes in 6MWD and the endurance test on the bicycle after CRT or after WBV training in patients with COPD | measured by endurance test on the bicycle (75% Max. Workload)before and after 12 weeks of training. This test will also be repeated after 6 weeks of training. | before and after 12 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06000696 -
Healthy at Home Pilot
|
||
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT04105075 -
COPD in Obese Patients
|
||
Recruiting |
NCT05825261 -
Exploring Novel Biomarkers for Emphysema Detection
|
||
Active, not recruiting |
NCT04075331 -
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial
|
Phase 2/Phase 3 | |
Terminated |
NCT03640260 -
Respiratory Regulation With Biofeedback in COPD
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|
||
Withdrawn |
NCT04210050 -
Sleep Ventilation for Patients With Advanced Hypercapnic COPD
|
N/A | |
Terminated |
NCT03284203 -
Feasibility of At-Home Handheld Spirometry
|
N/A | |
Recruiting |
NCT06110403 -
Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06040424 -
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Recruiting |
NCT04868357 -
Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program
|
N/A | |
Completed |
NCT01892566 -
Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
|
N/A | |
Completed |
NCT04119856 -
Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD
|
N/A | |
Completed |
NCT04485741 -
Strados System at Center of Excellence
|
||
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT04860375 -
Multidisciplinary Management of Severe COPD
|
N/A |